Brooks Laboratories’ arm enters into distribution and supply agreement with Armas Pharmaceuticals

10 May 2022 Evaluate

Brooks Laboratories’ subsidiary -- Brooks Steriscience has entered into Distribution and Supply Agreement with Armas Pharmaceuticals, Inc. USA, a multi-source pharmaceutical company, having head quartered in Freehold, New Jersey, United States.

Through this agreement Brooks Steriscience intends to supply Carbapenem products in the United States of America and its commonwealths and territories thereof, including Puerto Rico. Globally, Carbapenems are a $2 billion plus opportunity with limited players having dedicated capabilities to manufacture these products for the regulated markets.

Brooks Laboratories is a pharmaceutical contract research and manufacturing services company.

Brooks Laboratories Share Price

165.50 3.20 (1.97%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.